Literature DB >> 2613443

Effect of divalent cations on structure-function relationships of the antitumor protein alpha-sarcin.

A Martínez del Pozo1, M Gasset, M Oñaderra, J G Gavilanes.   

Abstract

alpha-Sarcin binds one Zn(II) cation per protein molecule, with a Kd value of 0.9 mM, determined by equilibrium dialysis experiments. Ca(II), Mg(II), and Mn(II) do not bind to alpha-sarcin. Cd(II) and Co(II) also behave as Zn(II). The binding produces local modifications on the protein conformation affecting the microenvironment of tryptophan residues. The three cations modify the fluorescence emission of the protein. The near-u.v. circular dichroism spectrum of the protein is also altered. The binding of Zn(II) and related cations does not modify the secondary structure of the protein. The ribonucleolytic activity of alpha-sarcin is inhibited upon Zn(II) binding, but no alteration of the ability of the protein to aggregate phospholipid vesicles has been observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613443     DOI: 10.1111/j.1399-3011.1989.tb00711.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  3 in total

1.  Translocation of alpha-sarcin across the lipid bilayer of asolectin vesicles.

Authors:  M Oñaderra; J M Mancheño; M Gasset; J Lacadena; G Schiavo; A Martínez del Pozo; J G Gavilanes
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

2.  Kinetic study of the cytotoxic effect of alpha-sarcin, a ribosome inactivating protein from Aspergillus giganteus, on tumour cell lines: protein biosynthesis inhibition and cell binding.

Authors:  J Turnay; N Olmo; A Jiménez; M A Lizarbe; J G Gavilanes
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

3.  Substitution of histidine-137 by glutamine abolishes the catalytic activity of the ribosome-inactivating protein alpha-sarcin.

Authors:  J Lacadena; J M Mancheño; A Martinez-Ruiz; A Martínez del Pozo; M Gasset; M Oñaderra; J G Gavilanes
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.